Resultados de la búsqueda 121-130 of 1832 for Birth Control Palette
... population. Patients will be enrolled over a three year period across ... control (HC) donors. Alternate Doses and Dosing Schedules of Belantamab ...
Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...
A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls. Rochester, Minn ...
... (controls); the application of potential biomarkers of risk to this archival tissue set; and, the discovery of new, potentially relevant biomarkers of risk ...
... population. Patients will be enrolled over a three year period across approximately 25 geographically diverse academic as well as community based sites ...
... control (HC) donors. A Study to Evaluate Maximizing Anti-PD-1 Therapy By ... population. Patients will be enrolled over a three year period across ...
... control during Induction have not improved in recent COG trials. The current phase 3 trial seeks to improve the event-free survival (EFS) for children with ...
This randomized, active controlled ... Controls. Rochester, Minn. The purpose of this ... population that currently receives protons and better evaluate its ...
This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?